Long-term benefit of one thrombolytic over another.
Grobman
B J
BJ
D003327:Coronary Disease / Q000188:drug therapy* / Q000209:etiology; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D010960:Plasminogen Activators / Q000008:administration & dosage*; D013300:Streptokinase / Q000008:administration & dosage*; D013927:Thrombosis / Q000150:complications / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
D005343:Fibrinolytic Agents; D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator